The AMPLITUDE clinical research study is exploring an investigational study drug for APOL1-mediated proteinuric kidney disease — a type of chronic kidney disease that occurs in the Black community. You can learn more about the study and refer a patient on this website.
This website contains information for healthcare professionals only.
AMPLITUDE_HCP Study Website_v5.0_08Apr2024_en-US
©2024. All Rights Reserved.
